Take control of the time between invoice and payment
Release working capital from your invoices for biotech and pharmaceuticals innovation
Stop delaying payments. Start earning from them.
- Transform your payables into profits through SAP Taulia’s solutions, which facilitated over $50B in funding in 2025.
- Free up the trapped cash between invoice and payment to fund R&D pipelines, clinical trials, and specialized laboratory upgrades.
- Shield your supply chain against raw material shortages and critical manufacturing disruptions using secure technology backed by SAP.
Unlock the hidden liquidity from your supply chain with SAP Taulia
Developing life-saving therapies requires balancing surging R&D expenditures and prolonged clinical trial timelines against volatile global supply chains. SAP Taulia improves cash flow, giving biotech and pharmaceutical leaders the financial agility to protect operating margins and secure critical research and manufacturing networks.
Unlock cash and financial agility with SAP Taulia:
- Turn your day-to-day payables into opportunities for value.
- Pivot your working capital strategy without switching software or processes.
- Deploy capital efficiently with SAP Taulia’s Multifunder, accessing 40+ funders via a single agreement.
- Scale with an SAP-backed, AI-driven solution that understands your unique data.
Grow your free cash flow at scale
Transform your payables into a powerful source of liquidity. By optimizing payment terms, you can unlock significant cash flow and boost it by up to 25%.
Strengthen supplier relationships
A healthier supply chain starts with healthier suppliers. Give your suppliers the control and flexibility they need with our intuitive portal, allowing them to get paid early and manage their cash flow.
Boost efficiency and realize a fast ROI
Eliminate the manual workload that plagues traditional supply chain finance programs. Our automation and deep integration deliver measurable value and a rapid return on investment.
Mitigate unnecessary financial risk
SAP Taulia’s Multifunder capabilities provide the option of additional liquidity to support growth and maintain stability, irrespective of market constraints or single-funder capacity limitations.
SAP Taulia directly impacts financial performance
in supplier invoices enrolled (86%) within 12 months for a global pharmaceuticals leader.
in early payments accelerated in 12 months for a pharmaceuticals company.
in working capital improvement for a multinational pharmaceuticals company
Trusted by world-leading biotech and pharmaceuticals companies
Pfizer and SAP Taulia: Insights into Digital Finance
Pfizer and SAP Taulia discuss key insights from their partnership, including evaluating capabilities and fostering strong partnerships. The discussion covers managing financial systems, e-commerce, and process mining, highlighting the constant variety and challenges as the most inspiring aspects of the work.
Learn more
Cash Flow Optimization for Biotech and Pharmaceuticals
From AI-driven drug discovery to gamechanging vaccine treatments, biotech and pharma firms are helping drive a period of rapid industry innovation. But at the same time, they face a series of sizeable challenges — including four related specifically to their supply chains.
Accelerate liquidity: Three levers to free cash from payables
Can you balance cash flow, working capital, and supplier relationships in today’s volatile environment? See how SAP Taulia Payables Finance keeps your supply chain moving without switching your software or disrupting existing relationships.
Instant release. Free up cash from your accounts receivable
Discover how SAP Taulia’s embedded solution provides access to debt-free, scalable financing that adapts to your company’s requirements without costly third-party integrations.
Contact us
Find out more about SAP Taulia.
Click the link below to send us an enquiry, one of our expert will be in touch to help.